Financings in Brief: Endocare
This article was originally published in The Gray Sheet
Executive Summary
Endocare: Secures two-year, $1.5 mil. borrowing facility through partnerships managed by venture capital firm Technology Funding. Endocare, which has developed the CryoCare cryosurgery system for treatment of prostate cancer, says this facility provides necessary working capital "for aggressively marketing" the CryoCare system. "It also provides a foundation to support long-term development of our third-stage, office-based therapy product for prostate enlargement," the company says...